The significant regulation of both collagen I and fibronectin gene expression in SFBs by miR-26a convincingly supports the hypothesis that miR-26a functions as a key player during fibrosis progression which is associated with SSc pathogenesis. This evidence concerns the gene FN1 and systemic sclerosis.